261 related articles for article (PubMed ID: 30508691)
1. Serum gut microbe-dependent trimethylamine N-oxide improves the prediction of future cardiovascular disease in a community-based general population.
Zheng L; Zheng J; Xie Y; Li Z; Guo X; Sun G; Sun Z; Xing F; Sun Y
Atherosclerosis; 2019 Jan; 280():126-131. PubMed ID: 30508691
[TBL] [Abstract][Full Text] [Related]
2. Trimethylamine-N-oxide (TMAO) determined by LC-MS/MS: distribution and correlates in the population-based PopGen cohort.
Gessner A; di Giuseppe R; Koch M; Fromm MF; Lieb W; Maas R
Clin Chem Lab Med; 2020 Apr; 58(5):733-740. PubMed ID: 32084001
[TBL] [Abstract][Full Text] [Related]
3. Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study.
Tang WHW; Li XS; Wu Y; Wang Z; Khaw KT; Wareham NJ; Nieuwdorp M; Boekholdt SM; Hazen SL
Am Heart J; 2021 Jun; 236():80-86. PubMed ID: 33626384
[TBL] [Abstract][Full Text] [Related]
4. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
5. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
[TBL] [Abstract][Full Text] [Related]
6. [Distribution characteristics of trimethylamine N-oxide and its association with gut microbiota].
Wang S; Xia GH; He Y; Liao SX; Yin J; Sheng HF; Zhou HW
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):455-60. PubMed ID: 27113169
[TBL] [Abstract][Full Text] [Related]
7. Transferrin predicts trimethylamine-N-oxide levels and is a potential biomarker of cardiovascular disease.
Bean LD; Wing JJ; Harris RE; Smart SM; Raman SV; Milks MW
BMC Cardiovasc Disord; 2022 May; 22(1):209. PubMed ID: 35538408
[TBL] [Abstract][Full Text] [Related]
8. Plasma trimethylamine N-oxide, a gut microbe-generated phosphatidylcholine metabolite, is associated with autism spectrum disorders.
Quan L; Yi J; Zhao Y; Zhang F; Shi XT; Feng Z; Miller HL
Neurotoxicology; 2020 Jan; 76():93-98. PubMed ID: 31704102
[TBL] [Abstract][Full Text] [Related]
9. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
[TBL] [Abstract][Full Text] [Related]
10. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients.
Nie J; Xie L; Zhao BX; Li Y; Qiu B; Zhu F; Li GF; He M; Wang Y; Wang B; Liu S; Zhang H; Guo H; Cai Y; Huo Y; Hou FF; Xu X; Qin X
Stroke; 2018 Sep; 49(9):2021-2028. PubMed ID: 30354996
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
13. The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada.
Mente A; Chalcraft K; Ak H; Davis AD; Lonn E; Miller R; Potter MA; Yusuf S; Anand SS; McQueen MJ
Can J Cardiol; 2015 Sep; 31(9):1189-94. PubMed ID: 26239008
[TBL] [Abstract][Full Text] [Related]
14. Association of the trimethylamine N-oxide with cardiovascular risk and vascular alterations in middle-aged patients with risk factors for cardiovascular diseases.
Spasova N; Somleva D; Krastev B; Ilieva R; Borizanova A; Svinarov D; Kinova E; Goudev A
Biosci Rep; 2024 Apr; 44(5):. PubMed ID: 38669041
[TBL] [Abstract][Full Text] [Related]
15. Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke.
Sun T; Zhang Y; Yin J; Peng X; Zhou L; Huang S; Wen Y; Cao B; Chen L; Li X; Yang W; Tan A; Cheng J; Liu L
J Atheroscler Thromb; 2021 Apr; 28(4):320-328. PubMed ID: 32641646
[TBL] [Abstract][Full Text] [Related]
16. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
Kaysen GA; Johansen KL; Chertow GM; Dalrymple LS; Kornak J; Grimes B; Dwyer T; Chassy AW; Fiehn O
J Ren Nutr; 2015 Jul; 25(4):351-6. PubMed ID: 25802017
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand.
Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Tatsanavivat P; Sritara P; Phrommintikul A
Sci Rep; 2021 Jul; 11(1):14963. PubMed ID: 34294762
[TBL] [Abstract][Full Text] [Related]
19. Dynamic Changes in Gut Microbiota-Derived Metabolite Trimethylamine-N-Oxide and Risk of Type 2 Diabetes Mellitus: Potential for Dietary Changes in Diabetes Prevention.
Huang Y; Wu Y; Zhang Y; Bai H; Peng R; Ruan W; Zhang Q; Cai E; Ma M; Zhao Y; Lu Y; Zheng L
Nutrients; 2024 May; 16(11):. PubMed ID: 38892643
[TBL] [Abstract][Full Text] [Related]
20. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
